{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:01:38Z","timestamp":1777399298242,"version":"3.51.4"},"reference-count":92,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10556","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T08:00:40Z","timestamp":1565078440000},"source":"Crossref","is-referenced-by-count":2,"title":["Targeting heterotopic ossification by inhibiting activin receptor\u2011like kinase 2 function (Review)"],"prefix":"10.3892","author":[{"given":"Fuli","family":"Shi","sequence":"first","affiliation":[{"name":"Jiangxi Province Key Laboratory of Tumor Pathogens and Molecular Pathology, Department of Pathophysiology, School of Basic Medicine Sciences, Nanchang University Medical College, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Gao","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Tumor Pathogens and Molecular Pathology, Department of Pathophysiology, School of Basic Medicine Sciences, Nanchang University Medical College, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junrong","family":"Zou","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Tumor Pathogens and Molecular Pathology, Department of Pathophysiology, School of Basic Medicine Sciences, Nanchang University Medical College, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ying","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Tumor Pathogens and Molecular Pathology, Department of Pathophysiology, School of Basic Medicine Sciences, Nanchang University Medical College, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Tumor Pathogens and Molecular Pathology, Department of Pathophysiology, School of Basic Medicine Sciences, Nanchang University Medical College, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"key20200713233646_b1-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/BOT.0000000000000666","article-title":"Heterotopic ossification: A review of current understanding, treatment, and future","volume":"30","author":"Edwards","year":"2016","journal-title":"J Orthop Trauma"},{"key":"key20200713233646_b2-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.scr.2015.11.017","article-title":"Generation of integration free induced pluripotent stem cells from fibrodysplasia ossificans progressiva (FOP) patients from urine samples","volume":"16","author":"Hildebrand","year":"2016","journal-title":"Stem Cell Res"},{"key":"key20200713233646_b3-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJMoa011262","article-title":"Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia","volume":"346","author":"Shore","year":"2002","journal-title":"N Engl J Med"},{"key":"key20200713233646_b4-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/978-1-4939-8651-4_32","article-title":"Morpholino-mediated exon skipping targeting human ACVR1\/ALK2 for fibrodysplasia ossificans progressiva","volume":"1828","author":"Maruyama","year":"2018","journal-title":"Methods Mol Biol"},{"key":"key20200713233646_b5-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41467-018-02872-2","article-title":"Activin-dependent signaling in fibro\/adipogenic progenitors causes fibrodysplasia ossificans progressiva","volume":"9","author":"Lees-Shepard","year":"2018","journal-title":"Nat Commun"},{"key":"key20200713233646_b6-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","article-title":"TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease","volume":"4","author":"Wu","year":"2016","journal-title":"Bone Res"},{"key":"key20200713233646_b7-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.febslet.2015.04.004","article-title":"Elimination of BMP7 from the developing limb mesenchyme leads to articular cartilage degeneration and synovial inflammation with increased age","volume":"589","author":"Abula","year":"2015","journal-title":"FEBS Lett"},{"key":"key20200713233646_b8-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/cen.13584","article-title":"Progressive osseous heteroplasia caused by a mosaic GNAS mutation","volume":"88","author":"Pereda","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20200713233646_b9-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/stem.1633","article-title":"Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification","volume":"32","author":"Culbert","year":"2014","journal-title":"Stem Cells"},{"key":"key20200713233646_b10-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1086\/302724","article-title":"Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31","volume":"66","author":"Feldman","year":"2000","journal-title":"Am J Hum Genet"},{"key":"key20200713233646_b11-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/nm.3314","article-title":"Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification","volume":"19","author":"Regard","year":"2013","journal-title":"Nat Med"},{"key":"key20200713233646_b12-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2106\/JBJS.H.00792","article-title":"Heterotopic ossification in high-energy wartime extremity injuries: Prevalence and risk factors","volume":"91","author":"Forsberg","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"key20200713233646_b13-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.berh.2007.11.007","article-title":"Fibrodysplasia ossificans progressiva","volume":"22","author":"Kaplan","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key20200713233646_b14-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1542\/peds.2007-1980","article-title":"Early diagnosis of fibrodysplasia ossificans progressiva","volume":"121","author":"Kaplan","year":"2008","journal-title":"Pediatrics"},{"key":"key20200713233646_b15-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.2106\/JBJS.J.00776","article-title":"Heterotopic ossification following combat-related trauma","volume":"92","author":"Potter","year":"2010","journal-title":"J Bone Joint Surg Am"},{"key":"key20200713233646_b16-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"309287","DOI":"10.1155\/2011\/309287","article-title":"Animal models of typical heterotopic ossification","volume":"2011","author":"Kan","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"key20200713233646_b17-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1302\/2046-3758.18.2000102","article-title":"Blast injuries and heterotopic ossification","volume":"1","author":"Alfieri","year":"2012","journal-title":"Bone Joint Res"},{"key":"key20200713233646_b18-mmr-20-04-2979","first-page":"346","article-title":"Heterotopic ossification","volume":"43","author":"Shehab","year":"2002","journal-title":"J Nucl Med"},{"key":"key20200713233646_b19-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11999-015-4266-1","article-title":"What risk factors predict recurrence of heterotopic ossification after excision in combat-related amputations?","volume":"473","author":"Pavey","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"key20200713233646_b20-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fneur.2018.00408","article-title":"Trauma-induced heterotopic ossification regulates the blood-nerve barrier","volume":"9","author":"Gugala","year":"2018","journal-title":"Front Neurol"},{"key":"key20200713233646_b21-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/cts.12552","article-title":"Treatments and preventative measures for trauma-induced heterotopic ossification: A review","volume":"11","author":"Juarez","year":"2018","journal-title":"Clin Transl Sci"},{"key":"key20200713233646_b22-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fbioe.2017.00073","article-title":"Cyclic tensile strain can play a role in directing both intramembranous and endochondral ossification of mesenchymal stem cells","volume":"5","author":"Carroll","year":"2017","journal-title":"Front Bioeng Biotechnol"},{"key":"key20200713233646_b23-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/jbmr.3235","article-title":"The expansion of heterotopic bone in fibrodysplasia ossificans progressiva is activin A-dependent","volume":"32","author":"Upadhyay","year":"2017","journal-title":"J Bone Miner Res"},{"key":"key20200713233646_b24-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bone.2017.08.025","article-title":"Heterotopic ossification: Mechanistic insights and clinical challenges","volume":"109","author":"Xu","year":"2018","journal-title":"Bone"},{"key":"key20200713233646_b25-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"652","DOI":"10.2106\/JBJS.H.01177","article-title":"Identification of progenitor cells that contribute to heterotopic skeletogenesis","volume":"91","author":"Lounev","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"key20200713233646_b26-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.2106\/00004623-200312000-00010","article-title":"In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification","volume":"85","author":"Glaser","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"key20200713233646_b27-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3928\/01477447-20140430-07","article-title":"Evaluation of the cellular origins of heterotopic ossification","volume":"37","author":"Kan","year":"2014","journal-title":"Orthopedics"},{"key":"key20200713233646_b28-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4614-0254-1_4","article-title":"Heterotopic ossification following musculoskeletal trauma: Modeling stem and progenitor cells in their microenvironment","volume":"720","author":"Ji","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"key20200713233646_b29-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/nm.2252","article-title":"Conversion of vascular endothelial cells into multipotent stem-like cells","volume":"16","author":"Medici","year":"2010","journal-title":"Nat Med"},{"key":"key20200713233646_b30-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2353\/ajpath.2007.060692","article-title":"Hypoxic adipocytes pattern early heterotopic bone formation","volume":"170","author":"Olmsted-Davis","year":"2007","journal-title":"Am J Pathol"},{"key":"key20200713233646_b31-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/sctm.16-0347","article-title":"Progenitors in peripheral nerves launch heterotopic ossification","volume":"6","author":"Olmsted-Davis","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"key20200713233646_b32-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1007\/s11999-012-2459-4","article-title":"Immune and inflammatory pathways are involved in inherent bone marrow ossification","volume":"470","author":"Gurkan","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"key20200713233646_b33-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jor.20359","article-title":"Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells","volume":"25","author":"Luu","year":"2007","journal-title":"J Orthop Res"},{"key":"key20200713233646_b34-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/08977190412331279890","article-title":"Bone morphogenetic proteins","volume":"22","author":"Chen","year":"2004","journal-title":"Growth Factors"},{"key":"key20200713233646_b35-mmr-20-04-2979","first-page":"15005","article-title":"TGF-\u03b2\/BMP signaling and other molecular events: Regulation of osteoblastogenesis and bone formation","author":"Rahman","year":"015","journal-title":"Bone Res"},{"key":"key20200713233646_b36-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bone.2015.05.025","article-title":"Bone morphogenetic protein signaling in bone homeostasis","volume":"80","author":"S\u00e1nchez-Duffhues","year":"2015","journal-title":"Bone"},{"key":"key20200713233646_b37-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11914-011-0046-3","article-title":"Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva","volume":"9","author":"Shore","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"key20200713233646_b38-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.morpho.2016.01.004","article-title":"Fibrodysplasia ossificans progressiva. A case report and focus on the BMP signaling pathway","volume":"100","author":"Bouvard","year":"2016","journal-title":"Morphologie"},{"key":"key20200713233646_b39-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bone.2017.04.014","article-title":"Conserved signaling pathways underlying heterotopic ossification","volume":"109","author":"Kan","year":"2018","journal-title":"Bone"},{"key":"key20200713233646_b40-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva","volume":"287","author":"Chaikuad","year":"2012","journal-title":"J Biol Chem"},{"key":"key20200713233646_b41-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.mod.2003.12.003","article-title":"Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells","volume":"121","author":"Dudas","year":"2004","journal-title":"Mech Dev"},{"key":"key20200713233646_b42-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.bbamcr.2017.08.009","article-title":"AMPK downregulates ALK2 via increasing the interaction between Smurf1 and Smad6, leading to inhibition of osteogenic differentiation","volume":"1864","author":"Lin","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"key20200713233646_b43-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1016\/j.bmcl.2013.03.113","article-title":"Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe","volume":"23","author":"Engers","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"key20200713233646_b44-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bone.2018.03.015","article-title":"Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders","volume":"111","author":"Machiya","year":"2018","journal-title":"Bone"},{"key":"key20200713233646_b45-mmr-20-04-2979","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.091110","article-title":"ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation","volume":"25","author":"van Dinther","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key20200713233646_b46-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/jbmr.1637","article-title":"An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva","volume":"27","author":"Chakkalakal","year":"2012","journal-title":"J Bone Miner Res"},{"key":"key20200713233646_b47-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci Transl Med"},{"key":"key20200713233646_b48-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tibs.2015.11.010","article-title":"A door opens for fibrodysplasia ossificans progressiva","volume":"41","author":"Katagiri","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"key20200713233646_b49-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic [corrected] ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat Med"},{"key":"key20200713233646_b50-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713233646_b51-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12964-015-0104-z","article-title":"Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B","volume":"13","author":"Olsen","year":"2015","journal-title":"Cell Commun Signal"},{"key":"key20200713233646_b52-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J Bone Miner Res"},{"key":"key20200713233646_b53-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00264-018-3845-7","article-title":"Heterotopic ossification around the knee after tibial nailing and ipsilateral antegrade and retrograde femoral nailing in the treatment of floating knee injuries","volume":"42","author":"Kent","year":"2018","journal-title":"Int Orthop"},{"key":"key20200713233646_b54-mmr-20-04-2979","first-page":"399","article-title":"Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients","volume":"24","author":"Wang","year":"2011","journal-title":"Zhongguo Gu Shang"},{"key":"key20200713233646_b55-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"255ra132","DOI":"10.1126\/scitranslmed.3008810","article-title":"Treatment of heterotopic ossification through remote ATP hydrolysis","volume":"6","author":"Peterson","year":"2014","journal-title":"Sci Transl Med"},{"key":"key20200713233646_b56-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1682\/JRRD.2014.01.0019","article-title":"Novel mouse model of spinal cord injury-induced heterotopic ossification","volume":"51","author":"Kang","year":"2014","journal-title":"J Rehabil Res Dev"},{"key":"key20200713233646_b57-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jcp.20118","article-title":"Primary mouse embryonic fibroblasts: A model of mesenchymal cartilage formation","volume":"200","author":"Lengner","year":"2004","journal-title":"J Cell Physiol"},{"key":"key20200713233646_b58-mmr-20-04-2979","author":"Sun","year":"2018"},{"key":"key20200713233646_b59-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2106\/JBJS.N.01156","article-title":"Effect of naproxen prophylaxis on heterotopic ossification following hip arthroscopy: A double-blind randomized placebo-controlled trial","volume":"97","author":"Beckmann","journal-title":"J Bone Joint Surg Am"},{"key":"key20200713233646_b60-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/cts.12300","article-title":"Locally delivered nonsteroidal antiinflammatory drug: A potential option for heterotopic ossification prevention","volume":"8","author":"Rivera","year":"2015","journal-title":"Clin Transl Sci"},{"key":"key20200713233646_b61-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/0363546515618623","article-title":"Selective COX-2 inhibitors significantly reduce the occurrence of heterotopic ossification after Hip arthroscopic surgery","volume":"44","author":"Rath","year":"2016","journal-title":"Am J Sports Med"},{"key":"key20200713233646_b62-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1177\/0363546514526361","article-title":"The effect of NSAID prophylaxis and operative variables on heterotopic ossification after Hip arthroscopy","volume":"42","author":"Beckmann","year":"2014","journal-title":"Am J Sports Med"},{"key":"key20200713233646_b63-mmr-20-04-2979","first-page":"CD003321","article-title":"Pharmacological interventions for treating acute heterotopic ossification","author":"Haran","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713233646_b64-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s11999-014-3591-0","article-title":"Heterotopic ossification of the elbow treated with surgical resection: Risk factors, bony ankylosis, and complications","volume":"472","author":"Salazar","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"key20200713233646_b65-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ijrobp.2014.03.008","article-title":"Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: A case-control analysis","volume":"89","author":"Sheybani","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20200713233646_b66-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/21678707.2017.1304211","article-title":"Hard targets for a second skeleton: Therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)","volume":"5","author":"Kaplan","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"key":"key20200713233646_b67-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1242\/dmm.027573","article-title":"High-throughput screening for modulators of ACVR1 transcription: Discovery of potential therapeutics for fibrodysplasia ossificans progressiva","volume":"9","author":"Cappato","year":"2016","journal-title":"Dis Model Mech"},{"key":"key20200713233646_b68-mmr-20-04-2979","article-title":"Gremlin, Noggin, Chordin and follistatin differentially modulate BMP induced suppression of androgen secretion by bovine ovarian theca cells","author":"Glister","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"key20200713233646_b69-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nchembio.2007.54","article-title":"Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism","volume":"4","author":"Yu","year":"2008","journal-title":"Nat Chem Biol"},{"key":"key20200713233646_b70-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1016\/j.bmcl.2008.06.052","article-title":"Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors","volume":"18","author":"Cuny","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"key20200713233646_b71-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1021\/cb300655w","article-title":"Development of an ALK2-biased BMP type I receptor kinase inhibitor","volume":"8","author":"Mohedas","year":"2013","journal-title":"ACS Chem Biol"},{"key":"key20200713233646_b72-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1021\/cb9002865","article-title":"In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors","volume":"5","author":"Hao","year":"2010","journal-title":"ACS Chem Biol"},{"key":"key20200713233646_b73-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/jpet.114.216903","article-title":"Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration","volume":"351","author":"Tsugawa","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"key20200713233646_b74-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1021\/jm501177w","article-title":"Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants","volume":"57","author":"Mohedas","journal-title":"J Med Chem"},{"key":"key20200713233646_b75-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2017.09.004","article-title":"Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2","volume":"109","author":"Williams","year":"2018","journal-title":"Bone"},{"key":"key20200713233646_b76-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"366ra163","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci Transl Med"},{"key":"key20200713233646_b77-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1750-1172-8-145","article-title":"Identification and characterization of regulatory elements in the promoter of ACVR1, the gene mutated in Fibrodysplasia Ossificans Progressiva","volume":"8","author":"Giacopelli","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"key20200713233646_b78-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/hep.27543","article-title":"Regulatory MiR-148a-ACVR1\/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma","volume":"61","author":"Li","year":"2015","journal-title":"Hepatology"},{"key":"key20200713233646_b79-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"23796","DOI":"10.1074\/jbc.M114.577387","article-title":"MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription","volume":"289","author":"Zumbrennen-Bullough","year":"2014","journal-title":"J Biol Chem"},{"key":"key20200713233646_b80-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/ijms13022063","article-title":"ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a","volume":"13","author":"Song","year":"2012","journal-title":"Int J Mol Sci"},{"key":"key20200713233646_b81-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"e50958","DOI":"10.1371\/journal.pone.0050958","article-title":"The role of the 3\u2032UTR region in the regulation of the ACVR1\/Alk-2 gene expression","volume":"7","author":"Mura","year":"2012","journal-title":"PLoS One"},{"key":"key20200713233646_b82-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4161\/rna.8.5.16153","article-title":"MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2","volume":"8","author":"Karbiener","year":"2011","journal-title":"RNA Biol"},{"key":"key20200713233646_b83-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"e69096","DOI":"10.1371\/journal.pone.0069096","article-title":"Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: Inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"key":"key20200713233646_b84-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/gt.2011.193","article-title":"Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva","volume":"19","author":"Takahashi","year":"2012","journal-title":"Gene Ther"},{"key":"key20200713233646_b85-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/gt.2011.152","article-title":"Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting","volume":"19","author":"Kaplan","year":"2012","journal-title":"Gene Ther"},{"key":"key20200713233646_b86-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"key":"key20200713233646_b87-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.bbrc.2019.06.143","article-title":"Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation","volume":"516","author":"Miki","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713233646_b88-mmr-20-04-2979","first-page":"26","article-title":"Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice","volume":"31","author":"Yamamoto","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"key20200713233646_b89-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1750-1172-8-163","article-title":"Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: An open-labeled clinical trial","volume":"8","author":"Kitoh","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"key20200713233646_b90-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1517\/21678707.2013.825208","article-title":"From mysteries to medicines: Drug development for fibrodysplasia ossificans progressive","volume":"1","author":"Kaplan","year":"2013","journal-title":"Expert Opin Orphan Drugs"},{"issue":"pii","key":"key20200713233646_b91-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"E989","DOI":"10.3390\/ijms19040989","article-title":"The horizon of a therapy for rare genetic diseases: A \u2018Druggable\u2019 future for fibrodysplasia ossificans progressiva","volume":"19","author":"Cappato","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20200713233646_b92-mmr-20-04-2979","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.07.023","article-title":"ACVR1-Fc suppresses BMP signaling and chondro-osseous differentiation in an in vitro model of Fibrodysplasia ossificans progressiva","volume":"92","author":"Pang","year":"2016","journal-title":"Bone"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T18:50:41Z","timestamp":1721587841000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":92,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10556","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]}}}